Navigation Links
Sales of Energy-Boosting Diet Pills Skyrocket as the Economy Falters

SALT LAKE CITY, Dec. 16 /PRNewswire/ -- Can a high-energy diet pill really save your job? It seems that many people think so. Even as car manufacturers, clothing makers and other retailers are seeing a significant drop in sales due to the declining economy, diet pill maker Zoller(R) Laboratories is reporting dramatically increased sales of Zantrex-3(R), their high-energy diet pill.


Zantrex-3's reputation has spread from college campuses (where students have been using it for years to increase cognitive performance, alertness and drive) to the workplace, where employees around the country are now using Zantrex on the job to stay alert, positive and productive.

"People are worried about the economy and, frankly, they're worried about whether they'll have a job next year," says Gina Daines, spokesperson for Zoller Labs. "They know that employers are being forced to make cutbacks and are paying close attention to employees' performance. And it may sound callous, but if you're an employer and you absolutely have to fire someone to stay in business, who are you going to choose? The guy nodding off at his desk, or the alert go-getter who actually gets things done? The choice seems obvious to me... and apparently to a lot of other people."

A recent article by Reuters pointed to the growing use of "brain-boosting drugs" in the workplace. Long a trend at colleges and universities, where students need help to cram for exams, older Americans are now turning to natural stimulants to help increase their mental capabilities and maintain their focus. And according to many physicians and psychologists, there's nothing wrong with that. In fact, boosting your ability to focus is really a "smart" thing to do. As reported in the December article, "We should welcome new methods of improving our brain function," wrote Henry Greely of Stanford Law School in California and Barbara Sahakian, a psychiatry professor from the University of Cambridge (England).

Zantrex-3 Sales Continue To Spike

"Since September we've seen a large spike in Zantrex sales while the supplement industry itself is facing declining sales and profits," says Ms. Daines. "Our figures show that both blue and white collar workers are turning to Zantrex for an instant kick and a sustained energy boost to power through the day and maintain optimum on-the-job performance."

Scientific evidence supports the energy-boosting and performance-enhancing capabilities of Zantrex-3's key ingredients. Several published clinical studies have shown that these ingredients can increase concentration, help users focus more clearly on a specific task and improve short-term memory.

Better yet, when you feel more energetic and more productive at work, your mood improves. "And let's face it," says Ms. Daines, "energetic, positive people are easier to hire and easier to keep. Enthusiasm and performance go a long way, especially in today's workplace."

If skyrocketing sales are any indication, it seems that millions of Americans, young and old, are convinced that taking Zantrex-3 to boost energy and improve performance is the really smart thing to do.

Web site:

SOURCE Zoller Laboratories
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mannatech Launches Phase One of New Sales and Training Tools
2. NBTY Announces Preliminary Unaudited Net Sales Results For August 2007
3. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
4. Plexus Systems Ranks in Top Third of the 2007 Inc. 5,000 with Three-Year Sales Growth of 226%
5. Resonant Medical Appoints New Vice President of Global Sales
6. portionpals(R) Sales Reach a Whopping 250,000 Units in 3 Months!
7. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
8. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
9. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
10. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
11. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
Post Your Comments:
(Date:11/27/2015)... ... 27, 2015 , ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces ... This is one of Joplin's most famous and beautiful concert posters. The concert was ... in Ann Arbor. The According to Hawley, "It is hard to believe that Joplin's ...
(Date:11/26/2015)... MI (PRWEB) , ... November 26, 2015 , ... ... for substance abuse located in central Michigan, have come together on Thanksgiving Day ... specially produced video, available for viewing on the Serenity Point YouTube channel, patients ...
(Date:11/26/2015)... Toronto, ON and Cambridge, ON (PRWEB) , ... ... ... announced today the availability of a real-time eReferral system for diagnostic imaging in ... CTs, ultrasounds, X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic ...
(Date:11/26/2015)... ... ... The Catalent Applied Drug Delivery Institute today announced a ... selection in early phase drug development. The first of these is to be ... UK’s emerging life sciences companies, corporate partners, and investors, at Milton Park, Oxford, ...
(Date:11/26/2015)... San Antonio, TX (PRWEB) , ... November 26, 2015 , ... ... accomplishment! On November 19, 2015, our surgeons performed their 6,000th free flap breast ... Ledoux , “We wake up every day excited to rebuild lives and it’s an ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
(Date:11/25/2015)... , Nov. 25, 2015 ... addition of the "Global Brain Monitoring ... offering. --> ) has ... Brain Monitoring Devices Market 2015-2019" report ... and Markets ( ) has announced ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
Breaking Medicine Technology: